Company Overview
Leucid Bio Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Thursday 27 November 2014, so this is a well established company. Leucid Bio Ltd has been in business for 11 years and 4 months. The accounts status is small and the accounts are next due on Tuesday 31 March 2026.
Registered Address

Building 1000 Beach Drive, Waterbeach, Cambridge, CB25 9PD
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameLEUCID BIO LTD
Company Number09331486
Registered Office AddressBuilding 1000 Beach Drive
 Waterbeach
 CB25 9PD
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date27/11/2014
Accounting Reference Date Day30
Accounting Reference Date Month6
Accounts Next Due Date31/03/2027
Accounts Last Made Up Date30/06/2025
Accounts Account CategorySMALL
Returns Next Due Date25/12/2016
Returns Last Made Up Date27/11/2015
Directors & Members
Show Resigned
Martin Diggle - Director
(British, 64 years old, born May 1962)
Appointed 24 June 2021
 Active
Peter Finan - Director
(British, 59 years old, born July 1967)
Appointed 26 June 2017
 Active
Heikki Lanckriet - Director
(Belgian, 49 years old, born May 1977)
Appointed 13 February 2025
 Active
Ian Miscampbell - Director
(British, 64 years old, born February 1962)
Appointed 24 June 2021
 Active
Filippo Petti - Director
(American, 50 years old, born April 1976)
Appointed 17 July 2023
 Active
Secretaries
Show Resigned
Mark Docherty - Secretary
Appointed 30 November 2023
 Active
Other Company Directorships
Martin Diggle
OXFORD ENDOVASCULAR LIMITED
PROTEOME SCIENCES PLC
SCANCELL HOLDINGS PLC
VULPES INVESTMENT MANAGEMENT UK LTD
Peter Finan
ADORX THERAPEUTICS LIMITED
BIOINDUSTRY ASSOCIATION
CALDAN THERAPEUTICS LIMITED
CLYDE BIOSCIENCES LIMITED
CURVE THERAPEUTICS LIMITED
ENTERPRISE THERAPEUTICS HOLDINGS LIMITED
ENTERPRISE THERAPEUTICS LTD
EPIDAREX CAPITAL PARTNERS LIMITED
EPIDAREX EXEED LIMITED
EPIDAREX MANAGEMENT LTD
EPSILOGEN LTD
ETERNYGEN UK LTD.
KINSENSUS LIMITED
KNOWLEDGE TRANSFER NETWORK LIMITED
LARIO THERAPEUTICS LIMITED
LUNAC THERAPEUTICS LIMITED
NUTHURST FIBRE PROJECT LTD
THEOLYTICS LTD
THERAVIEW CONSULTING LTD
TMEM16A LIMITED
Heikki Lanckriet
4BASEBIO DISCOVERY LIMITED
4BASEBIO UK LTD
4BASEBIO UK SOCIETAS
ASTRANET SYSTEMS LTD
I2I CAPITAL LIMITED
NEOPHORE LIMITED
Ian Miscampbell
AMERIGO LIMITED
ANONTEC LIMITED
AZERIA THERAPEUTICS LIMITED
CAMGRAIN (SERVICES) LIMITED
CRAWFORD HEALTHCARE LIMITED
CRT PIONEER CIP GP LIMITED
CRT PIONEER GP LIMITED
DERMS DEVELOPMENT LIMITED
ELLESBOROUGH GOLF CLUB LIMITED
EXCALIBUR FUND MANAGERS LIMITED
HEALTH PERCEPTION (UK) LIMITED
ISLA CAPITAL LLP
ISLA CAPITAL PARTNERS LIMITED
KORDEL LIMITED
MACROPHAGE PHARMA LIMITED
MENOLIFE LIMITED
NEOPHORE LIMITED
OPTIMA HEALTHCARE LIMITED
ROSANTO PHARMACEUTICALS LTD
SIXTH ELEMENT CAPITAL LLP
TRUST WILLIAM LIMITED
W R TRUSTEE COMPANY LIMITED
WFM (NEWCO) LIMITED
YORK PHARMA (R & D) LIMITED
YORK PHARMA (UK) LIMITED
YORK PHARMA PLC
Filippo Petti
No companies found
Balance Sheet Unlock full report
Accounts Date 30-Jun-2025 30-Nov-2016 30-Nov-2015
Balance Sheet
Fixed Assets 0 0 0
Current Assets 0 0 300
Creditors Due Within One Year 0 0 0
Working Cap 0 0 300
Total Assets Less Current Liabilities 0 0 300
Long-term Liabilities 0 0 0
Net Assets 0 0 300
Share Capital & Reserves
Share Cap 0 0 0
Profit & Loss Reserves 0 0 300
Other Reserves 0 0 0
Shareholders Funds 0 0 300
Common Size Financial Analysis Unlock full report
Accounts Date 30-Jun-2025 30-Nov-2016 30-Nov-2015
Tangible Fixed Assets - - -
Fixed Assets - - 0.0%
Stocks Inventory - - 0.0%
Debtors - - 100.0%
Cash Bank In Hand - - 0.0%
Current Assets - - 100.0%
Creditors Due Within One Year - - 0.0%
Net Current Assets Liabilities - - 100.0%
Creditors Due After One Year - - 0.0%
Accruals Deferred Income - - 0.0%
Provisions For Liabilities Charges - - 0.0%
Net Assets Liabilities Including Pension Asset Liability - - 100.0%
Called Up Share Capital - - 0.0%
Share Capital Allotted Called Up Paid - - 0.0%
Profit Loss Account Reserve - - 100.0%
Shareholder Funds - - 100.0%
Capital Employed - - -
Total Assets Less Current Liabilities - - 100.0%
Financial Ratio Analysis Unlock full report
Accounts Date 30-Jun-2025 30-Nov-2016 30-Nov-2015
Liquidity Ratio 0.0 0.0 300.0
Solvency Ratio - - ∞
Reserves to Assets - - 1.0
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 1
Assets and Debt Analysis Unlock full report
Accounts Date 30-Jun-2025 30-Nov-2016 30-Nov-2015
Assets 0 0 300
Debt 0 0 0
Net Assets/Debt 0 0 300

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is nil.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is nil.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is nil.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around CB25 9PD
INOTEC AMD LIMITED
UNIT 7340, BUILDING 7300 CAMBRIDGE RESEARCH PARK, BEACH DRIVE, WATERBEACH, CAMBRIDGE, CB25 9PD
CAMBRIDGE ONLINE SYSTEMS LIMITED
5TH FLOOR ROTUNDA CUBO STANDARD COURT, PARK ROW, NOTTINGHAM, UNITED KINGDOM, CB25 9PD
Document Filings
Confirmation statement made on 27 November 2025 with updates
Appointment of Mr Heikki Lanckriet as a director on 13 February 2025
Statement of capital following an allotment of shares on 26 February 2025
Statement of capital following an allotment of shares on 13 February 2025
Resolutions
Memorandum and Articles of Association
Confirmation statement made on 27 November 2024 with updates
Second filing of a statement of capital following an allotment of shares on 18 December 2023
Statement of capital following an allotment of shares on 30 August 2024
Resolutions
Registered office address changed from 30 Broad Street Great Cambourne Cambridge CB23 6HJ England to Building 1000 Beach Drive Waterbeach Cambridge CB25 9PD on 23 January 2024
Statement of capital following an allotment of shares on 18 December 2023
Confirmation statement made on 27 November 2023 with no updates
Appointment of Mr Mark James Docherty as a secretary on 30 November 2023
Termination of appointment of Margaret Daniel as a secretary on 18 October 2023
Satisfaction of charge 093314860001 in full
Registration of charge 093314860002, created on 21 August 2023
Appointment of Mr Filippo Joseph Petti as a director on 17 July 2023
Director's details changed for Mr Ian Alexander Francis Miscampbell on 24 August 2023
Termination of appointment of Artin Moussavi as a director on 10 February 2023
Confirmation statement made on 27 November 2022 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free